Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
21.3%
% of SBIO's 89 holdings also in CNCR
26.4%
% of CNCR's 72 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
ARCELLX, INC. | 3.2% | 1.7% | 1.7% |
|
GERON CORP | 1.7% | 1.4% | 1.4% |
 |
MERUS N.V. | 2.2% | 1.4% | 1.4% |
|
XENCOR INC | 1.1% | 1.8% | 1.1% |
|
IDEAYA BIOSCIENCES, INC. | 1.5% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to CNCR
|
CORCEPT THERAPEUTICS INC | 4.2% |
 |
ALKERMES PLC | 3.6% |
|
KRYSTAL BIOTECH, INC. | 3.4% |
|
CRINETICS PHARMACEUTICALS INC | 3.1% |
|
AVIDITY BIOSCIENCES INC | 2.7% |
|
PTC THERAPEUTICS INC | 2.5% |
|
DENALI THERAPEUTICS INC. | 2.3% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.1% |
|
ACADIA PHARMACEUTICALS INC | 2.1% |
|
VERICEL CORPORATION | 2.0% |
SBIO Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.3% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | -2.1% |
|
EXELIXIS INC | -2.0% |
|
JANUX THERAPEUTICS, INC. | -1.9% |
|
BRISTOL-MYERS SQUIBB CO | -1.8% |
|
MERSANA THERAPEUTICS, INC. | -1.7% |
|
BLUEPRINT MEDICINES CORP. | -1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | -1.7% |
|
SCHRODINGER, INC. | -1.7% |